Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities
Net increase (decrease) in net assets resulting from operations	$ 92,714	$ 58,958
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:
Net realized (gain) loss on investments	(764)	(265)
Net realized (gain) loss on foreign currency forward contracts	(36)	(14)
Net change in unrealized (appreciation) depreciation on investments	(2,741)	(3)
Net change in unrealized (appreciation) depreciation on interest rate swaps and options, inclusive of hedging effects	(1,298)	0
Net accretion on debt instruments	(8,641)	(5,053)
Net paydown gain on debt instruments	(2,649)	(861)
Interest received in-kind	(2,244)	(1,278)
Purchases and drawdowns of investments	(690,798)	(1,066,731)
Proceeds from sales and paydowns of investments	264,656	135,803
Net settlements on derivative contracts	36	14
Amortization of deferred financing costs	3,570	1,424
Amortization of deferred offering costs	1,098	497
Change in operating assets and liabilities:
(Increase) decrease in interest receivable	(2,500)	(5,225)
(Increase) decrease in other assets	(81)	(1,340)
(Increase) decrease in prepaid expenses	553	413
Increase (decrease) in interest payable	(5,161)	863
Increase (decrease) in accrued expenses and other liabilities payable to affiliate	(90)	(612)
Increase (decrease) in income incentive fees payable	1,253	2,013
Increase (decrease) in management fees payable	1,002	1,108
Increase (decrease) in deferred tax liability	999	216
Increase (decrease) in deferred income	(287)	104
Increase (decrease) in capital gains incentive fees payable	277	55
Net cash used in operating activities	(351,080)	(879,951)
Cash flows from financing activities
Dividends paid	(66,747)	(53,134)
Payments for repurchase of common shares	(38,095)	(487)
Proceeds from issuance of common shares	387,499	470,633
Borrowings on debt	807,700	1,309,408
Payments on debt	(761,500)	(722,200)
Payments for deferred financing costs	(1,763)	(7,838)
Payments for deferred offering costs	(880)	(627)
Net cash provided by financing activities	326,214	995,755
Net change in cash	(24,866)	115,804
Cash and restricted cash, beginning of period	161,064	62,706
Cash and restricted cash, end of period	136,198	178,510
Supplemental and non-cash information
Distributions reinvested	23,130	10,629
Cash paid during the period for interest	67,121	32,033
Dividends payable	16,550	11,567
The following table provides a reconciliation of cash and restricted cash reported within the consolidated statements of assets and liabilities:
Cash	73,634	144,701
Restricted cash	62,564	33,809
Total cash and restricted cash	136,198	178,510
Foreign currency forward contracts
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:
Net change in unrealized (appreciation) depreciation on foreign currency forward contracts	$ 52	$ (37)